Page last updated: 2024-08-23

1-deoxynojirimycin and Cancer of Skin

1-deoxynojirimycin has been researched along with Cancer of Skin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Parsons, PG; Takahashi, H	1

Other Studies

1 other study(ies) available for 1-deoxynojirimycin and Cancer of Skin

Article	Year
Rapid and reversible inhibition of tyrosinase activity by glucosidase inhibitors in human melanoma cells. The Journal of investigative dermatology, 1992, Volume: 98, Issue:4 Topics: 1-Deoxynojirimycin; Antibodies, Monoclonal; Antigens; Blotting, Western; Cell Survival; Chromatography, Affinity; Flow Cytometry; Glucosamine; Glucosidases; Humans; Indolizines; Melanocytes; Melanoma, Experimental; Methionine; Monophenol Monooxygenase; Skin Neoplasms; Subcellular Fractions; Sulfur Radioisotopes; Tumor Cells, Cultured	1992

Article

Year

Rapid and reversible inhibition of tyrosinase activity by glucosidase inhibitors in human melanoma cells.

The Journal of investigative dermatology, 1992, Volume: 98, Issue:4

Topics: 1-Deoxynojirimycin; Antibodies, Monoclonal; Antigens; Blotting, Western; Cell Survival; Chromatography, Affinity; Flow Cytometry; Glucosamine; Glucosidases; Humans; Indolizines; Melanocytes; Melanoma, Experimental; Methionine; Monophenol Monooxygenase; Skin Neoplasms; Subcellular Fractions; Sulfur Radioisotopes; Tumor Cells, Cultured

1992